Zalicus is a biopharmaceutical company focused on the discovery and development of treatments against pain and immune-inflammatory diseases. The company’s internal pipeline includes Z160 for chronic neuropathic pain and Z944 for acute and inflammatory pain. ZLCS has multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. For further information, visit the company’s Web site at www.zalicus.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: